Correlation Between Passage Bio and Inozyme Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Passage Bio and Inozyme Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Passage Bio and Inozyme Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Passage Bio and Inozyme Pharma, you can compare the effects of market volatilities on Passage Bio and Inozyme Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Passage Bio with a short position of Inozyme Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Passage Bio and Inozyme Pharma.

Diversification Opportunities for Passage Bio and Inozyme Pharma

0.69
  Correlation Coefficient

Poor diversification

The 3 months correlation between Passage and Inozyme is 0.69. Overlapping area represents the amount of risk that can be diversified away by holding Passage Bio and Inozyme Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inozyme Pharma and Passage Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Passage Bio are associated (or correlated) with Inozyme Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inozyme Pharma has no effect on the direction of Passage Bio i.e., Passage Bio and Inozyme Pharma go up and down completely randomly.

Pair Corralation between Passage Bio and Inozyme Pharma

Given the investment horizon of 90 days Passage Bio is expected to generate 2.03 times more return on investment than Inozyme Pharma. However, Passage Bio is 2.03 times more volatile than Inozyme Pharma. It trades about 0.0 of its potential returns per unit of risk. Inozyme Pharma is currently generating about -0.73 per unit of risk. If you would invest  66.00  in Passage Bio on August 28, 2024 and sell it today you would lose (4.00) from holding Passage Bio or give up 6.06% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Passage Bio  vs.  Inozyme Pharma

 Performance 
       Timeline  
Passage Bio 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Passage Bio has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Passage Bio is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.
Inozyme Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Inozyme Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Passage Bio and Inozyme Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Passage Bio and Inozyme Pharma

The main advantage of trading using opposite Passage Bio and Inozyme Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Passage Bio position performs unexpectedly, Inozyme Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inozyme Pharma will offset losses from the drop in Inozyme Pharma's long position.
The idea behind Passage Bio and Inozyme Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Other Complementary Tools

AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like